BioGenerator’s largest investment in any single company is paying off for St. Louis. Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. for the St. Louis company’s world-class research team, intellectual property and drug discovery assets.
{iframe}https://stlpartnership.com/biotech-startup-acquired-deal-100m/{/iframe}